[
    [
        {
            "time": "2021-04-01",
            "original_text": "社保QFII最新调仓！两类资金分歧巨大",
            "features": {
                "keywords": [
                    "社保",
                    "QFII",
                    "调仓",
                    "分歧"
                ],
                "sentiment_score": -0.5,
                "policy_related": "true",
                "investment_strategy": "true",
                "sector_focus": [
                    "金融"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "社保QFII最新调仓！两类资金分歧巨大",
                "Correlation": 5,
                "Sentiment": 5,
                "Importance": 6,
                "Impact": 5,
                "Duration": 6,
                "Entity_Density": 3,
                "Market_Scope": 8,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 7
            }
        },
        {
            "time": "2021-03-31",
            "original_text": "泰格医药做LP，一天豪掷5.2亿投资5家基金！",
            "features": {
                "keywords": [
                    "泰格医药",
                    "LP",
                    "投资",
                    "基金"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "泰格医药做LP，一天豪掷5.2亿投资5家基金！",
                "Correlation": 10,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 9,
                "Market_Scope": 5,
                "Time_Proximity": 8,
                "Headline_Structure": 9,
                "Source_Recency": 8
            }
        },
        {
            "time": "2021-03-31",
            "original_text": "1300亿医药巨头霸气做LP：一天内，官宣投了5家基金",
            "features": {
                "keywords": [
                    "医药",
                    "巨头",
                    "LP",
                    "投资"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "1300亿医药巨头霸气做LP：一天内，官宣投了5家基金",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 8,
                "Market_Scope": 4,
                "Time_Proximity": 7,
                "Headline_Structure": 9,
                "Source_Recency": 7
            }
        },
        {
            "time": "2021-03-30",
            "original_text": "泰格医药：公司合作的医药临床试验机构在全国大中小城市均有分布",
            "features": {
                "keywords": [
                    "泰格医药",
                    "临床试验",
                    "分布"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "泰格医药：公司合作的医药临床试验机构在全国大中小城市均有分布",
                "Correlation": 7,
                "Sentiment": 6,
                "Importance": 5,
                "Impact": 4,
                "Duration": 6,
                "Entity_Density": 8,
                "Market_Scope": 3,
                "Time_Proximity": 5,
                "Headline_Structure": 5,
                "Source_Recency": 6
            }
        },
        {
            "time": "2021-03-29",
            "original_text": "泰格医药：加快全球化布局，在国际市场上取得长足发展",
            "features": {
                "keywords": [
                    "泰格医药",
                    "全球化",
                    "国际市场",
                    "发展"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "泰格医药：加快全球化布局，在国际市场上取得长足发展",
                "Correlation": 8,
                "Sentiment": 7,
                "Importance": 7,
                "Impact": 6,
                "Duration": 8,
                "Entity_Density": 8,
                "Market_Scope": 5,
                "Time_Proximity": 6,
                "Headline_Structure": 6,
                "Source_Recency": 7
            }
        },
        {
            "time": "2021-03-28",
            "original_text": "东莞证券 - 泰格医药2020年年报点评：临床业务有望快速恢复，巨额合同正待消化【公司研究】",
            "features": {
                "keywords": [
                    "东莞证券",
                    "泰格医药",
                    "年报",
                    "临床业务",
                    "恢复",
                    "合同"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "东莞证券 - 泰格医药2020年年报点评：临床业务有望快速恢复，巨额合同正待消化【公司研究】",
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 7,
                "Duration": 7,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 6
            }
        },
        {
            "time": "2021-03-27",
            "original_text": "麦格理上调泰格医药目标价至146.48港元，维持中性评级",
            "features": {
                "keywords": [
                    "麦格理",
                    "泰格医药",
                    "目标价",
                    "中性评级"
                ],
                "sentiment_score": 0.5,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "麦格理上调泰格医药目标价至146.48港元，维持中性评级",
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 7,
                "Headline_Structure": 6,
                "Source_Recency": 7
            }
        },
        {
            "time": "2021-03-26",
            "original_text": "晨会聚焦210401重点关注纺织服装、医药生物、安克创新、药明康德、新和成、卓胜微、中芯国际-U、华熙生物、周大生、宇信科技",
            "features": {
                "keywords": [
                    "晨会聚焦",
                    "纺织服装",
                    "医药生物",
                    "安克创新",
                    "药明康德"
                ],
                "sentiment_score": 0.4,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药",
                    "科技",
                    "消费"
                ],
                "causal_factor": "false",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "晨会聚焦210401重点关注纺织服装、医药生物、安克创新、药明康德、新和成、卓胜微、中芯国际-U、华熙生物、周大生、宇信科技",
                "Correlation": 5,
                "Sentiment": 5,
                "Importance": 5,
                "Impact": 4,
                "Duration": 4,
                "Entity_Density": 4,
                "Market_Scope": 7,
                "Time_Proximity": 5,
                "Headline_Structure": 5,
                "Source_Recency": 5
            }
        },
        {
            "time": "2021-03-25",
            "original_text": "国内外需求同频共振，「医药外包服务」迎来黄金十年！",
            "features": {
                "keywords": [
                    "医药外包服务",
                    "需求",
                    "黄金十年"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "国内外需求同频共振，「医药外包服务」迎来黄金十年！",
                "Correlation": 7,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 7,
                "Duration": 9,
                "Entity_Density": 5,
                "Market_Scope": 9,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 7
            }
        },
        {
            "time": "2021-03-24",
            "original_text": "国信证券 - 泰格医药2020年报点评：业绩符合预期，国际化布局稳步推进【公司研究】",
            "features": {
                "keywords": [
                    "国信证券",
                    "泰格医药",
                    "年报",
                    "国际化布局"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "国信证券 - 泰格医药2020年报点评：业绩符合预期，国际化布局稳步推进【公司研究】",
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 7,
                "Duration": 7,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 6
            }
        }
    ]
]